46th week of 2015 patent applcation highlights part 8 |
Patent application number | Title | Published |
20150320614 | LENGTH-TO-SIDE SILHOUETTES OF ADULT DISPOSABLE ABSORBENT ARTICLES AND ARRAYS - In one embodiment, an array of packages may comprise two or more different sizes of disposable absorbent articles. The Product Length-to-Side Silhouette of a second absorbent article may be equal to or greater than a Product Length-to-Side Silhouette of a first absorbent article. And, an Array Average Product Length-to-Side Silhouette of first and second packages of the array may be from about 1.2 to about 1.6. | 2015-11-12 |
20150320615 | ABSORBENT ARTICLE HAVING FLUID FLOW CONTROL MEMBER - An absorbent article, the absorbent article being a personal hygiene article, includes a liquid permeable top sheet, a liquid impermeable back sheet, an absorbent core enclosed between the top sheet and the back sheet, and a fluid flow control member arranged between the top sheet and the backsheet. The fluid flow control member is a spacer fabric including a top layer, a bottom layer and an interconnecting layer of pile filaments between the top layer and the bottom layer. The spacer fabric has a ratio of thickness to basis weight at 15 kPa of at least 1.5·10 | 2015-11-12 |
20150320616 | ABSORBANT ARTICLE WITH ABSORBANT STRUCTURE WITH CROSS-DIRECTIONALLY ORIENTED PASSAGEWAY - The present invention is an absorbent article comprising at least one predominantly cross-directionally extending discontinuity, such as a slit, by which the absorbent core of the structure is adapted to form a z- and y-directionally opened passageway. | 2015-11-12 |
20150320617 | LAYERED ABSORBENT STRUCTURE WITH WICKING PERFORMANCE - The present invention relates to a layered absorbent structure in the form of a laminate including liquid storage layers comprising particulate superabsorbent material and adhesive fibers. Notably, the absorbent structure includes a wicking layer positioned between the liquid storage layers, with the wicking layer desirably acting to improve fluid spreading and rewet performance of the absorbent structure. The wicking layer preferably comprises airlaid cellulosic fibrous material such as wood pulp, and may optionally include superabsorbent polymer. A bonding pattern of the wicking layer is oriented to enhance wicking and rewet performance. | 2015-11-12 |
20150320618 | ABSORBENT ARTICLES HAVING A PULPLESS ABSORBENT CORE WITH IMPROVED PERFORMANCE - The embodiments provide an absorbent garment that has an absorbent core that provides for both good leakage and dryness performance. Absorbent garments having a pulpless synthetic core have comparable functionality when compared to more costly absorbent garments having an absorbent core comprising conventional amounts of fluff pulp. The absorbent garments of the embodiments incorporate features that provide good leakage performance and rewet values, while costing considerably less. | 2015-11-12 |
20150320619 | HIP-TO-SIDE SILHOUETTES OF ADULT DISPOSABLE ABSORBENT ARTICLES AND ARRAYS - In one embodiment, an array of packages may comprise two or more different sizes of disposable absorbent articles. The Product Hip-to-Side Silhouette of a second absorbent article may be equal to or greater than a Product Hip-to-Side Silhouette of a first absorbent article. And, an Array Average Product Hip-to-Side Silhouette of first and second packages of the array may be from about 2.2 to about 6.0. | 2015-11-12 |
20150320620 | LENGTH-TO-WAIST SILHOUETTES OF ADULT DISPOSABLE ABSORBENT ARTICLES AND ARRAYS - In one embodiment, an array of packages may comprise two or more different sizes of disposable absorbent articles. The Product Length-to-Waist Silhouette of a second absorbent article may be equal to or less than a Product Length-to-Waist Silhouette of a first absorbent article. And the Product Length-to-Waist Silhouette of a third absorbent article may be equal to or less than a Product Length-to-Waist Silhouette of a second absorbent article. And, an Array Average Product Length-to-Waist Silhouette of first and second packages of the array may be from about 1.1 to about 0.3. In another embodiment, a disposable absorbent article may have a Product Length-to-Waist Silhouette from 1.0 to about 0.3. | 2015-11-12 |
20150320621 | WAIST-TO-SIDE SILHOUETTES OF ADULT DISPOSABLE ABSORBENT ARTICLES AND ARRAYS - In one embodiment, an array of packages may comprise two or more different sizes of disposable absorbent articles. The Product Waist-to-Side Silhouette of a second absorbent article may be equal to or greater than a Product Waist-to-Side Silhouette of a first absorbent article. And, an Array Average Product Waist-to-Side Silhouette of first and second packages of the array may be from about 1.7 to about 6.0. In another embodiment, a disposable absorbent article has a Product Waist-to-Side Silhouette from 1.7 to about 6. | 2015-11-12 |
20150320622 | HIP-TO-WAIST SILHOUETTES OF ADULT DISPOSABLE ABSORBENT ARTICLES AND ARRAYS - In one embodiment, an array of packages may comprise three or more different sizes of disposable absorbent articles. The Product Hip-to-Waist Silhouette of a second absorbent article may be equal to or less than a Product Hip-to-Waist Silhouette of a first absorbent article. And the Product Hip-to-Waist Silhouette of a third absorbent article may be equal to or less than a Product Hip-to-Waist Silhouette of a second absorbent article. And, an Array Average Product Hip-to-Waist Silhouette of first and second packages of the array may be from about 1.1 to about 0.9. | 2015-11-12 |
20150320623 | POST-SURGICAL DRAIN MANAGEMENT GARMENT - A post-surgical drain management garment comprises a lightweight, disposable, wrap-around material with pouches for comfortable placement of surgical drains. The garment provides a wrap-around piece designed to keep the post-surgical drains secure while in the hospital, post-surgical facility, or other recovery facility. The garment is wrapped around the torso, arm, leg, or other body part of the patient and then closed with a secure closure. A post-surgical drain is slipped over the top or bottom of the garment and placed in a pouch. | 2015-11-12 |
20150320624 | PRONE CART - A prone cart for transporting a patient in a hospital or clinic setting is provided. The prone cart includes a frame having a pair of extension slides coupled thereto and first and second sets of wheels. An upper portion includes first and second moveably adjustable trays operably coupled to said extension slides. The second tray includes a plurality of apertures in at least one side rail and the first tray includes at least one locking spring pin operably receivable by one of said plurality of apertures. The prone cart also includes a patient support surface. | 2015-11-12 |
20150320625 | Method of apparatus for ingress and egress of chair - An armchair is mounted on a assembly which permits the entire chair to be simultaneously tilted and elevated to a selected operative position. | 2015-11-12 |
20150320626 | C-SPINE PRESSURE DISTRIBUTIVE SUPPORT - The invention provides a support device for supporting the anatomy of a patient or consumer. The support device has a bottom layer which is in contact with a surface, and a top layer which is in contact with the anatomy of the patient or consumer. The support device is formable into different configurations, depending on the anatomy being supported. | 2015-11-12 |
20150320627 | WHEELCHAIR AND COMBINED BED - A wheelchair includes a first link that supports a first bottom, a second link that supports a second bottom, a third link that supports a third bottom, a fourth link that supports a fourth bottom, a first base portion that supports a fifth bottom, and a first drive link. The first drive link has a first roller and a second roller. The second link and the third link are provided with rail portions respectively. The wheelchair has wheelchair link portion allows the first roller to slide in the rail portion of the second link, and allows the second roller to slide in the rail portion of the third link. | 2015-11-12 |
20150320629 | Connective Tissue Modification Cuff - A connective tissue modification cuff can be applied around a portion of the body and drawn tight. Integrated within the portion of the cuff that is pressed against the body is a plurality of variable compression beads. These variable compression beads comprise half spherical beads, half prolate spheroid beads, half oblate spheroid beads, or other similarly rounded structures that provide variably increasing pressure towards their high-points and gradually reduced pressure towards their low points. The cuff can be tightened down via a tensioning system that allows even tightening in small increments. Once in place, the person then stretches or uses the arm in order to apply the variable compression beads to the connective tissue under use. Such application works on the underlying connective tissue to reduce the pain and associated problems. | 2015-11-12 |
20150320630 | APPARATUS FOR LOCOMOTION THERAPY - Apparatus for locomotion therapy is provided which comprises a base ( | 2015-11-12 |
20150320631 | ASSISTIVE WALKING DEVICE WITH ADJUSTABLE DIMENSIONS - An adjustable walker includes a tubular frame construction having front and lateral telescoping tubes defining a walker space for a user. The lateral tubes have handgrips suitable for being grasped by a user. The front telescoping tubes are adjustable in length to adjust the width of the walker space for the user and the lateral telescoping tubes are adjustable in length to adjust the height of the handgrips. Locking mechanisms are provided for locking the front telescoping tubes and the lateral telescoping tubes. Actuators on the handgrips selectively unlock the locking mechanisms to allow a user to adjust the width of the walker space and for selectively unlocking the second locking to allow a user to adjust the height of said handgrips to adjust the height and/or width of the walker by use of said actuators on said handgrips without bending or letting go of the walker. | 2015-11-12 |
20150320632 | APPARATUS FOR UNLOADING A USER'S BODY WEIGHT DURING A PHYSICAL ACTIVITY OF SAID USER, PARTICULARLY FOR GAIT TRAINING OF SAID USER - The invention relates to an apparatus ( | 2015-11-12 |
20150320633 | AMBULATORY WALKER WITH SEAT - Described is a walker that is a front entry walker that surrounds the user with a frame on three sides and that includes a fold-down seat when needed. The frame includes a first side frame, a second side frame and a rear frame connected between the first and second side frames. The rear frame includes the seat such that when the seat is in the stowed position, the seat in conjunction with the first and second side frames collectively surround the user on at least three sides. Further, an adjustable arm rest is attached with each of the first and second side frames. Notably, each adjustable arm rest has a forearm support and corresponding brake system. | 2015-11-12 |
20150320634 | SCALP STIMULATION DEVICE - Arrangements directed to a scalp stimulation device are described. The scalp stimulation device can include a housing and a plurality of scalp engaging members. The plurality of scalp engaging members can be located at least partially within the housing. The scalp engaging members can be selectively extended from and/or selectively retracted into the housing. | 2015-11-12 |
20150320635 | MASSAGE MACHINE HAVING A TILTABLE BED PROVIDED WITH A SEAT - A massage machine has a base ( | 2015-11-12 |
20150320637 | WEARABLE PRESSURE POINT SYSTEM - Devices and method are disclosed for a wearable pressure point system for relieving pain, injury and tightness by applying pressure to specific tendons, ligaments, fascia, muscles and muscle groups. Devices comprise a compression system, including for example, a wearable harness, clamps, wraps and combinations thereof. | 2015-11-12 |
20150320638 | MILK BOTTLE ADAPTER - A cap for a milk container, in particular for a milk bottle, comprising a holder for securing the cap on the milk container, and a female connector element, which is arranged as a through-opening in the cap, for connection to a male connector element, wherein at least the female connector element has an antimicrobial surface at least in part. | 2015-11-12 |
20150320639 | Adaptor for Multidose Medical Container - An adaptor for coupling with a medical container filled with a number N of doses of a product including a gripping member for securing the adaptor to the medical container. The gripping member has at least one needle access port intended to face the outer surface of the septum of the medical container. The adaptor also includes a marking-device coupled to the needle access port, for designating to a user a not yet pierced area of said outer surface, for completing the next of the N successive piercings. | 2015-11-12 |
20150320640 | Method of Manufacturing a Medical Device - The invention relates to a method of manufacturing a medical device ( | 2015-11-12 |
20150320641 | PRESSURE-REGULATING VIAL ADAPTORS - In certain embodiments, a vial adaptor comprises a housing configured to couple the adaptor with a vial, an access channel, a regulator channel, and a regulator assembly. The access channel is configured to facilitate withdrawal of fluid from the vial when the adaptor is coupled to the vial. The regulator channel is configured to facilitate a flow of a regulating fluid from the regulator assembly to compensate for changes in volume of a medical fluid in the vial. In some embodiments, the regulator assembly includes a flexible member configured to expand and contract in accordance with changes in the volume of the medical fluid in the vial. In some embodiments, the flexible member is substantially free to expand and contract. In some embodiments, the flexible member is not partly or completely located in a rigid enclosure. | 2015-11-12 |
20150320642 | PRESSURE-REGULATING VIAL ADAPTORS - In certain embodiments, a vial adaptor comprises a housing configured to couple the adaptor with a vial, an access channel, a regulator channel, and a regulator assembly. The access channel is configured to facilitate withdrawal of fluid from the vial when the adaptor is coupled to the vial. The regulator channel is configured to facilitate a flow of a regulating fluid from the regulator assembly to compensate for changes in volume of a medical fluid in the vial. In some embodiments, the regulator assembly includes a flexible member configured to expand and contract in accordance with changes in the volume of the medical fluid in the vial. In some embodiments, the flexible member is substantially free to expand and contract. In some embodiments, the flexible member is not partly or completely located in a rigid enclosure. | 2015-11-12 |
20150320643 | SELF LEARNING MEDICATION STORAGE DEVICE - Compartments of a medication storage device are fitted with sensors to detect the presence of medication and the opening of compartment lids or doors. A controller monitors the sensor signals and sounds an alarm if medication is not removed from a compartment within a variance range about a target time. | 2015-11-12 |
20150320644 | NURSING BOTTLE NIPPLE AND AIR-VENTING SYSTEM - The nursing bottle nipple has a nipple portion integrally formed with an air-venting tube extending to the bottom of the bottle so that air can enter the bottle without mixing with the milk inside the bottle. An air inlet of the air-venting tube is integrally formed on the base portion of the nipple so that it cannot be covered by the collar that holds the nipple onto the neck of the bottle. A nursing bottle air-venting system is also disclosed. | 2015-11-12 |
20150320645 | DENTAL AND ENDODONTIC FILLING MATERIALS AND METHODS - Disclosed are endodontic filling materials and methods. A method for filling a dental root canal may include providing a hydrosetting filling material and inserting the hydrosetting filling material into the dental root canal, the material setting in the root canal to form a biocompatible filling. The hydrosetting filling material comprises a hydrogel former and a filler. The hydrogel former is at least one of a reactive organic hydrogel formers, an inorganic hydrogel formers, and a non-reactive organic hydrogel formers, and the filler is at least one of a self-hardening and a non-hardening filler. Plural filling material precursor compositions that collectively contain hydrogel formers and fillers may be provided. | 2015-11-12 |
20150320646 | DENTAL CURABLE COMPOSITION AND DENTAL FLOWABLE COMPOSITE RESIN - The present invention provides a dental curable composition suitable as a flowable composite resin. The dental curable composition, when in the form of a cured product, has excellent mechanical strength, polishability, and gloss retention, and, when in the form of a paste, has consistency appropriate for discharge through a needle attached to the tip of a syringe and exhibits good formability and handling properties after discharge through the needle. The present invention is a dental curable composition including: a polymerizable monomer (A); irregularly-shaped inorganic particles (B) having an average particle diameter of 0.1 to 0.3 μm and surface-treated with a silane coupling agent having a particular structure; and inorganic ultrafine particles (C) having an average particle diameter of 5 to 50 nm and surface-treated with a silane coupling agent having a particular structure, the dental curable composition containing 92.5 to 98 weight % of the irregularly-shaped inorganic particles (B) and 2 to 7.5 weight % of the inorganic ultrafine particles (C) relative to the amount of total inorganic particles and having a consistency of 25 to 55. | 2015-11-12 |
20150320647 | SOLID POWDERY COSMETIC COMPOSITION - The present invention relates to a cosmetic composition, comprising:—an oil phase in an amount of 20% by weight or more, preferably from 25% to 50% by weight, and more preferably from 28% to 45% by weight, relative to the total weight of the composition, said oil phase including preferably at least one non-volatile oil, more preferably at least one non-volatile hydrocarbon-based oil and/or at least one non-volatile silicone oil, —a pulverulent phase in an amount of 40% by weight or more, preferably from 50% to 75% by weight, and more preferably from 55% to 70% by weight, relative to the total weight of the composition, —at least one hydrophobic film-forming polymer, —the cosmetic composition is obtainable, and preferably obtained, by a process comprising the steps of: —mixing said oil phase, said hydrophobic film-forming polymer(s), said pulverulent phase, and at least one additional solvent to prepare a slurry; and —shaping said slurry in a container by compression and/or aspiration to prepare the cosmetic composition. | 2015-11-12 |
20150320648 | MATT-EFFECT COMPOSITION COMPRISING HYDROPHOBIC AEROGEL PARTICLES AND SILICONE ELASTOMER PARTICLES - The present invention relates to a cosmetic and/or dermatological composition comprising, in a physiologically acceptable medium: a) at least some hydrophobic aerogel particles, b) at least some silicone elastomer particles, c) at least one particle that absorbs sebum. The invention also relates to a process for making the skin matt and/or for reducing its shine. | 2015-11-12 |
20150320649 | ABRASIVE COATINGS FOR PEROXIDE-CONTAINING COMPOSITION - Described herein are oral care compositions comprising (i) a peroxide whitening agent, and (ii) an abrasive in the form of particles, wherein the particles are pre-coated with a coating layer composed of a coating material selected from at least one substantially saturated C | 2015-11-12 |
20150320650 | ANHYDROUS COSMETIC COMPOSITION - The present invention relates to an anhydrous cosmetic composition, comprising: (a) at least one oil phase including at least one oil; (b) at least one alcohol phase including at least one alcohol; and (c) at least one nonionic surfactant phase including at least one nonionic surfactant, wherein the amount of the (c) nonionic surfactant phase is less than 10% by weight relative to the total weight of the composition. The anhydrous cosmetic composition according to the present invention can provide multi-phase appearance, and can visually stimulate users of the cosmetic composition while maintaining good cosmetic effects. | 2015-11-12 |
20150320651 | FOAMED CLEANSER WITH SUSPENDED PARTICLES - One aspect of the invention is a new foam which includes a liquid having a plurality of bubbles therein and a plurality of particles suspended therein. The foam is made in a dispenser that suspends the bubbles in the liquid. The liquid may be a single liquid with particles therein or may be made from two liquids which are mixed together. The particles may be such that, prior to foaming the particles sink, float or are suspended in the liquid. | 2015-11-12 |
20150320652 | EMULSION COMPOSITION - An emulsion composition includes a compound having a diaminopyrimidine skeleton, at least one fatty acid component selected from the group consisting of a fatty acid having a total carbon number of 14 or more and a salt thereof, and an aqueous medium in an amount of 50% by mass or more with respect to the mass of the emulsion composition. The total amount of monohydric alcohol having a total carbon number of 3 or less and dihydric alcohol having a total carbon number of 3 or less is less than 10% by mass with respect to the mass of the emulsion composition. The emulsion composition has a pH of 6.5 or more. | 2015-11-12 |
20150320653 | COSMETIC BASE COMPOSITION AND ITS USE - The present invention relates to a cosmetic basic composition comprising hydroxypropylmethylcellulose (HPMC) modified with C15-C20 alkyl ether groups as thickener, Oleosomes and water, wherein the Oleosomes comprise at least one cosmetically active substance. The invention also relates to the use of the cosmetic basic composition in products of decorative cosmetics, personal care cosmetics and/or skin protection cosmetics. | 2015-11-12 |
20150320654 | Oral Care Compositions - Oral care composition comprises a stannous ion source and a thickener comprising at least 2 agents selected from the group consisting of: i) a linear sulfated polysaccharide; ii) a natural gum; iii) and a non-ionic cellulose derivative. A method for treating the oral cavity comprises administering to the oral cavity the oral care composition. | 2015-11-12 |
20150320655 | Oral Care Compositions - Oral care composition comprise a stannous ion source and a thickener consisting essentially of carrageenan and xanthan gum. A method for treating the oral cavity comprises administering the composition to the oral cavity in a toothpaste. | 2015-11-12 |
20150320656 | COSMETIC COMPOSITION OF HYDROPHOBIC SILICA AEROGEL PARTICLES AND AN ACRYLIC THICKENING POLYMER - The present invention relates to a cosmetic composition comprising hydrophobic silica aerogel particles and at least one particular acrylic thickening polymer. | 2015-11-12 |
20150320657 | SYSTEM AND METHOD OF COMPLIMENTARY DAY/NIGHT CHILDREN'S SKIN CREAM COMPOSITIONS - A new skin care system includes day and night skin cream compositions comprising nutrients and antioxidants for use by children between six months and eighteen years of age. The day skin cream composition provides protection from UV radiation and the night skin cream composition contains no sun protection ingredients and elevated levels of nutrients and antioxidants. A child-friendly bottle for each composition can be used by young children without difficulty. A fragrance included in each composition is popular with children, and the bottle for the day composition has graphics indicating day-time use and the bottle for the night composition has graphics indicating night-time use. The day composition is applied topically each day to the face after tooth-brushing, and the night composition is applied topically to the face each night after tooth-brushing. | 2015-11-12 |
20150320658 | Method of Forming a Polymer Inside the Hair Shaft Comprising Using a Salt of Thiosulfonic Acid - Method of forming a polymer inside the hair shaft. The polymer changes the mechanical properties of the hair, which provides styling advantages such as improved manageability. The method comprises applying an activating composition to the hair, wherein the activating composition comprises from about 0.5% to about 20% salt of thiosulfonic acid. Also related processes, uses, kits and regimens. | 2015-11-12 |
20150320659 | POLYOXYALKYLENE SUBSTITUTED ALKYLENE DIAMINES AND THEIR USE ON SKIN AND HAIR - This application is directed to hair and skin conditioning compositions which contain specific polyoxyalkylene substituted alkylene diamines. The polyoxyalkylene substituted alkylene diamines function as conditioning agents on hair and skin via cloud point deposition. The polyoxyalkylene substituted alkylene diamines in addition to functioning as conditioning agents on skin and hair by themselves also function to enhance deposition of lipophilic benefit agents such as for example fatty alcohols, esters of fatty acids, hydrophobic vitamin or vitamin complexes, natural or synthetic triglycerides including glyceryl esters and derivative, pearlescent waxes, hydrocarbon oils, siloxanes of silicones, perfume oils, super-fatting agents, water insoluble or slightly soluble organic sunscreens, micronized sunscreens, plant extracts, essential oils and hydrophobically modified pigments. | 2015-11-12 |
20150320660 | TRIAROMATIC AZOMETHINE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, METHOD OF IMPLEMENTATION AND USE - The present invention relates to azomethine-type direct dyes having a triaromatic unit of formula (I) below: and also the use thereof for dyeing keratin fibres, in particular human keratin fibres such as the hair. The invention also relates to a composition for dyeing keratin fibres, comprising, in a medium suitable for dyeing, such direct dyes. Another subject of the present invention is a method for dyeing keratin fibres using said dye composition. Finally, the present invention also relates to precursors of these direct dyes. | 2015-11-12 |
20150320661 | METHOD OF ENHANCING HAIR GROWTH - Methods and compositions for stimulating the growth of hair are disclosed wherein said compositions include a cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl compound represented by the formula I | 2015-11-12 |
20150320662 | Non-Petrochemically Derived Cationic Emulsifiers and Related Compositions and Methods - The invention includes a neutralized amino acid ester emulsifier, emulsions and compositions containing the emulsifier, and related methods. The emulsifier is a neutralized amino acid ester that is a reaction product of a neutral amino acid with a fatty alcohol and is represented by formula (I): | 2015-11-12 |
20150320663 | COSMETIC COMPOSITION COMPRISING AN AEQUEOUS DISPERSION OF HYDROPHOBIC SILICA AEROGEL PARTICLES AND A PARTICULAR ALCOHOL - The present invention relates to a method for the cosmetic treatment of keratin fibres, in particular human keratin fibres such as the hair, characterized in that it consists in applying an effective amount of a cosmetic composition comprising an aqueous dispersion of hydrophobic silica aerogel particles comprising at least one alcohol of formula (I) below, the optical isomers thereof and the solvates thereof, in particular the hydrates thereof: in which formula (I): R | 2015-11-12 |
20150320664 | COSMETIC COMPOSITION COMPRISING HYDROPHOBIC SILICA AEROGEL PARTICLES AND A FIXING POLYMER - The present invention relates to a cosmetic composition comprising hydrophobic silica aerogel particles and one or more hydrophilic fixing polymers. | 2015-11-12 |
20150320665 | Peroxide-Stable Oral Care Compositions - Described herein are oral care compositions comprising (i) a whitening complex comprising crosslinked polyvinylpyrrolidone complexed with hydrogen peroxide, and (ii) a hydrogen peroxide stabilizing agent comprising a clay comprising a lithium magnesium silicate or a sodium magnesium silicate, or a combination thereof. | 2015-11-12 |
20150320666 | Hair Fixative Compositions - A hair fixative composition includes at least one fixative polymer, a solvent system and, optionally, a propellant. The polymer is derived from at least one acid-containing monomer, at least one N-alkyl(meth)acrylamide and, optionally, an alkyl(meth)acrylate. | 2015-11-12 |
20150320667 | MOLECULARLY IMPRINTED POLYMER FOR SELECTIVELY TRAPPING ODOROUS MOLECULES - The invention relates to the use of molecularly imprinted polymer(s) or MIPs, of odorous molecule(s), as deodorant agent in particular for selectively trapping molecules that are the cause of human body odour. More particularly by using MIPs which may be obtained via polymerization, preferably via radical polymerization, of a mixture of: i) optionally one or more polymerization initiator(s); ii) one or more functional monomer(s); iii) one or more crosslinking agent(s); and iv) one or more porogenic solvent(s); it being understood that the polymerization a) or b) is performed in the presence v) of one or more “templates” of target molecule(s) responsible for human body odour. Another subject of the invention concerns a process for preparing MIPs as defined previously, MIPs obtained via this process, and a cosmetic composition comprising at least one MIP as defined previously. Unexpectedly, it appears that the MIPs make it possible to specifically trap precursors of odorous molecules and odorous molecules that may be used in cosmetic formulations, especially those that are the cause of the unpleasant odour of sweat. | 2015-11-12 |
20150320668 | COMPOSITIONS AND METHOD FOR THERMAL PROTECTION OF HAIR - This invention details a method for providing thermal protection to human hair by applying an aerosolized polymer system to the hair before heat treatment. It has been found that acrylate polymers provide good protection from the damaging affects of curling irons and straightening irons and afford improvements in the look and feel of the treated hair. | 2015-11-12 |
20150320669 | Oral Care Compositions for Tooth Whitening - Described herein are oral care compositions (for tooth whitening) comprising a thickening system comprising a first thickening agent and a second thickening agent, wherein the first thickening agent comprises greater than 15 wt % of the mixture of the first and second thickening agents in the thickening system. The compositions comprise crosslinked polyvinylpyrrolidone complexed with hydrogen peroxide with a thickening system comprising silica and crosslinked polyvinylpyrrolidone. | 2015-11-12 |
20150320670 | HAIR CARE POLYMER - The invention relates to a hair care composition comprising at least one cationic film forming polymer selected from the group of Polyquaternium and at least one quaternized hyperbranched polymer having end-groups of formula (I) characterized in that said quaternized hyperbranched polymer is obtainable by preparation of a hyperbranched polymer having dimethylamino end groups by condensation of 2-dodecen-1-ylsuccinic anhydride, diisopropanolamine and N,N-bis[3-(dimethylamino)propyl]amine followed by quaternization of the dimethylamino end-groups to end groups of formula (I). | 2015-11-12 |
20150320671 | SUNSCREEN COMPOSITIONS CONTAINING A UV-ABSORBING POLYGLYCEROL AND A NON-UV-ABSORBING POLYGLYCEROL - A sunscreen composition including a polymer composition that contains a UV-absorbing polyglycerol having a UV-absorbing chromophore chemically bound thereto, and a cosmetically-acceptable topical carrier that contains at least one percent by weight of the sunscreen composition of a non-UV-absorbing polyglycerol, based on total weight of the sunscreen composition. | 2015-11-12 |
20150320672 | Mixable Multi-Functional Product and Process for Keratin Fibers - A mixable multi-functional composition for application to keratin fibers such as hair, lashes or brows comprising at least one volatile solvent, at least one siloxane resin, at least one montmorillonite mineral, optionally at least one non-volatile oil, and optionally at least one wax; and a method for coloring keratin fibers comprising the steps of sequentially applying to the fibers, in any order, at least one mixable composition and at least one pigmented composition, wherein upon application the mixable composition mixes and combines with the pigmented composition in the wet state to form a final mixed composition that upon drying forms a compatible and homogeneous film. | 2015-11-12 |
20150320673 | COSMETIC SOLID COMPOSITION COMPRISING A NON VOLATILE HYDROCARBONATED OIL, WAXES AND A HIGH CONTENT FROM NON VOLATILE PHENYLATED SILICONE OIL - The present invention relates to solid compositions for making up and/or caring for the skin and/or the lips, comprising at least one fatty phase comprising: —from 5 to 30% by weight of non volatile hydrocarbonated apolar oil(s), or mixture thereof, relative to the total weight of the composition, —from 43 to 90% by weight of total content of non volatile silicone oil(s) relative to the total weight of the composition, wherein at least one of said non volatile silicone oil(s) is a non volatile phenylated silicon oil, and—from 3 to 30% by weight of wax(es), or mixture thereof, relative to the total weight of the composition. | 2015-11-12 |
20150320674 | Compositions Comprising Synthetic Waxes - The present invention relates to certain novel synthetic wax powder and cosmetic composition comprising such synthetic wax powders. The present invention also relates to processes for manufacturing the wax powder having an irregular particle shape, methods of making cosmetic and personal care compositions and the use of such cosmetic compositions in topical applications. | 2015-11-12 |
20150320675 | Modified Release Osmotic Pump for PH-Responsive Drug Delivery - In one aspect, the invention relates to controlled-release devices and methods of using same, alone or in combination with other agents, to deliver pharmaceutical agents, and more particularly to deliver birth control agent, fertility agents, hormone replacement agents, cervical ripening agents, agents to prevent a sexually transmitted disease, agents to treat a sexually transmitted disease, biologics, agents to treat a mucosal infection, agents to treat uterine fibroids, agents to treat reproductive cancers, agents to treat nausea gravidarum, and/or agents to treat endometriosis. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention. | 2015-11-12 |
20150320676 | TOPICAL DRUG FOR TREATING APHTHAE - Topical drugs for treating aphthae, wherein the topical drugs are in the form of a film-shaped dosage form. The topical drugs include a film made of a water-swellable or water-soluble polymer or polymer mixture, and at least one active ingredient selected from the group of tanning agents and essential oils. | 2015-11-12 |
20150320677 | EFFERVESCENT TABLET FORMULATIONS OF DAPOXETINE AND A PDE5 INHIBITOR - The present invention relates to effervescent tablet formulations of dapoxetine or a pharmaceutically acceptable salt thereof and a phosphodiesterase type 5 inhibitor or a pharmaceutically acceptable salt thereof. The present invention further relates to a process for preparing such a formulation and to the use thereof in the treatment of erectile dysfunction. | 2015-11-12 |
20150320678 | GEL COMPOSITIONS - Topical gel composition comprising ingenol-3-angelate and a silicone. | 2015-11-12 |
20150320679 | GEL COMPOSITIONS - Novel aqueous topical gel compositions comprising ingenol-3-angelate. | 2015-11-12 |
20150320680 | INJECTABLE COMPOSITION CONTAINING CHLOROTHIAZIDE - The present invention relates to stable ready to use injectable liquid composition of chlorothiazide or its pharmaceutically acceptable salts. | 2015-11-12 |
20150320681 | PROTOCELLS AND THEIR USE FOR TARGETED DELIVERY OF MULTICOMPONENT CARGOS TO CANCER CELLS - Various embodiments provide materials and methods for synthesizing protocells for use in targeted delivery of cargo components to cancer cells. In one embodiment, the lipid bilayer can be fused to the porous particle core to form a protocell. The lipid bilayer can be modified with targeting ligands or other ligands to achieve targeted delivery of cargo components that are loaded within the protocell to a target cell, e.g., a type of cancer. Shielding materials can be conjugated to the surface of the lipid bilayer to reduce undesired non-specific binding. | 2015-11-12 |
20150320682 | NANOPARTICULATE MEGESTROL FORMULATIONS - The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about | 2015-11-12 |
20150320683 | PROCESS FOR THE PRODUCTION OF DISCRETE SOLID EXTRUDED PARTICLES - The present invention relates to a process for the production of discrete solid extruded particles comprising dispersion droplets, to such particles as well as to the use of such particles in food, feed, pharmaceutical and personal care applications. | 2015-11-12 |
20150320684 | REHYDRATABLE PHARMACEUTICAL PRODUCT - A pharmaceutical product comprising lyophilised polymer matrix including a biologically active compound, of particular utility for embolisation, having improved rehydration properties is packaged in an airtight package under vacuum. | 2015-11-12 |
20150320685 | PHARMACEUTICAL COMPOSITIONS - Methods and compositions are provided which comprise effective amounts of analgesic to treat a subject, including reducing or eliminating an adverse effect associated with the analgesic. | 2015-11-12 |
20150320686 | ORAL DOSAGE FORMS FOR OXYGEN-CONTAINING ACTIVE AGENTS AND OXYL-CONTAINING POLYMER - The disclosed invention is drawn to pharmaceutical tablets that provide delivery of active agents having at least three oxygen-containing groups, as well as a second active ingredient. Non-limiting examples of three oxygen-containing group active agents include guaifenesin, codeine, hydrocodone, and their pharmaceutically acceptable salts. In one embodiment, a pharmaceutical tablet for oral administration once every 12 hours is provided. The tablet includes a first active agent that is a tri-oxy active agent, a second active agent, and a release rate controlling non-ionic oxyl-containing hydrophilic polymer. The total oxyl content of the hydrophilic polymer in the tablet is about 4×10 | 2015-11-12 |
20150320687 | PHARMACEUTICAL COMPOSITIONS CONTAINING A DGAT1 INHIBITOR - The present invention relates to a pharmaceutical composition comprising
| 2015-11-12 |
20150320688 | TABLET QUICKLY DISINTEGRATING IN THE ORAL CAVITY AND METHOD FOR PRODUCING THE SAME - The invention relates to a tablet which is rapidly disintegrated in an oral cavity containing an active ingredient at a high content and a production method thereof. That is, the present invention provides a tablet which is rapidly disintegrated in an oral cavity containing an active ingredient in not less than 25% of the total weight, having a disintegration time of within 40 seconds and an absolute hardness of 1.8 N/mm | 2015-11-12 |
20150320689 | ABUSE DETERRENT IMMEDIATE RELEASE COATED RESERVOIR SOLID DOSAGE FORM - An abuse deterrent immediate release coated reservoir solid dosage form that releases the drug at a desired rate for quick onset of action when a single unit or prescribed units of the dosage form are orally administered but exhibits a reduced rate of release when more than the prescribed number of units, are administered. | 2015-11-12 |
20150320690 | TAMPER RESISTANT IMMEDIATE RELEASE CAPSULE FORMULATION COMPRISING TAPENTADOL - The invention is directed to an immediate release capsule which mitigates the abuse of Tapentadol or physiologically acceptable salt thereof by direct intravenous injection. The capsule comprises a tamper resistant formulation which when mixed with water and heated, results in a turbid, bubbling mixture that is not injectable with a standard insulin syringe. | 2015-11-12 |
20150320691 | USE OF MAGNESIUM STEARATE IN DRY POWDER FORMULATIONS FOR INHALATION - Addition of magnesium stearate to a powder formulation for inhalation comprising carrier particles and an active ingredient bearing a group susceptible to hydrolysis is useful for inhibiting or reducing the chemical degradation of the active ingredient. | 2015-11-12 |
20150320692 | APPLICATION OF MALTOTRIOSE-COATED 4TH GENERATION POLYPROPYLENEIMINE DENDRIMER PPI-G4-DS-MAL-III - The application of maltotriose-coated 4th generation polypropyleneimine dendrimer PPI-G4-DS-Mal-III containing 80-95% of peripherial amines groups coated with maltotriose particles to make a drug for treating neoplastic proliferation diseases, particularly chronic lymphocytic leukemia. | 2015-11-12 |
20150320693 | VIRAL VECTOR NANOCAPSULE FOR TARGETING GENE THERAPY AND ITS PREPARATION - The invention provides novel methods, materials and systems that can be used to generate viral vectors having altered tissue and cell targeting abilities. In illustrative embodiments of the invention, the specificity of lentiviral vectors was modulated by a thin polymer shell that synthesized and coupled to the viral envelope in situ. The polymer shell can confers such vectors with new targeting ability via agents such as cyclic RGD (cRGD) peptides that are coupled to the polymer shell. These polymer encapsulated viral vectors exhibit a number of highly desirable characteristics including a higher thermal stability, resistance to serum inactivation in vivo, and an ability to infect dividing and non-dividing cells with high efficiencies. | 2015-11-12 |
20150320694 | MUCOADHESIVE NANOPARTICLE DELIVERY SYSTEM - The present disclosure relates generally to a mucoadhesive nanoparticle delivery system. The nanoparticles are formed from amphiphilic macromolecules conjugated to a mucosal targeting moiety in such a manner that the surface of the nanoparticle is coated with the targeting moiety. The surface density of the targeting moiety can be tuned for adjustable targeting of the nanoparticles to a mucosal site without substantially compromising the stability of the particles. The particles were found to have high loading efficiency and sustained release properties at the mucosal site. The present disclosure also relates to polymers and macromolecules useful in the preparation of the mucoadhesive nanoparticles, as well as compositions, methods, commercial packages, kits and uses related thereto. | 2015-11-12 |
20150320695 | DOSAGE FORM FOR INSERTION INTO THE MOUTH - Oral dosage forms as a biodegradable, water soluble film for delivering pharmaceutically active agents, to patients through insertion into the mouth of patient and methods for administering pharmaceutically active agents to patients by insertion into the mouth to provide selective uptake of said agents through the mucosa and thus avoiding the gastrointestinal tract. | 2015-11-12 |
20150320696 | COMBINATION THERAPY FOR CANCER - The present invention relates to a combination therapy for the treatment of cancer, particularly to combinations of terpinen-4-ol and at least one additional anti-cancer therapeutic agent. The combination therapy of the present invention shows enhanced anti-cancerous therapeutic effects compared to the effect of each of the components administered alone. In some embodiments, the combination therapy provide for a synergistic anti-cancer effect. | 2015-11-12 |
20150320697 | Methods For Bone Treatment By Modulating An Arachidonic Acid Metabolic or Signaling Pathway - Methods for promoting osteogenesis to accelerate or enhance bone fracture healing, treat bone defects, and enhance bone formation are disclosed. The methods modulate an arachidonic acid metabolic or signaling pathway in general, and, in particular, utilize 5-lipoxygenase inhibitors. These molecules can be delivered alone or in combination with one or more agents that inhibit bone resorption, regulate calcium resorption from bone, enhance bone accumulation, enhance bone formation, induce bone formation, impair growth of microorganisms, reduce inflammation, and/or reduce pain. | 2015-11-12 |
20150320698 | USE OF THE PHYTOCANNABINOID CANNABIDIVARIN (CBDV) IN THE TREATMENT OF EPILEPSY - This invention relates to the use of the phytocannabinoid cannabidivarin (CBDV) and combinations of the phytocannabinoid CBDV with tetrahydrocannabivarin (THCV) and cannabidiol (CBD) in the treatment of epilepsy. The invention further relates to the use of the phytocannabinoid CBDV in combination with standard anti-epileptic drugs (SAEDs). Preferably the SAED is one of ethosuximide, valproate or phenobarbital. | 2015-11-12 |
20150320699 | Pharmaceutical Composition Containing Lutein and Antioxidant for Treating and Preventing Human Disease - The present invention is to providing a new preparation including complex of a medical compound with lutein, astaxanthin and antioxidant. The new preparation includes stabilized liposome preparation, sustained release preparation and polymeric micelles preparation which used as delivery systems for lutein, astaxanthin and antioxidant. The new preparation significantly increases bioavailability of lutein and astaxanthin and uses for treatment and prevention of eyes and other disease. | 2015-11-12 |
20150320700 | Geranium oil and constituents thereof for treatment of neurodegenerative diseases - The invention relates to the use of effective amount of | 2015-11-12 |
20150320701 | TOPICAL ORAL COMPOSITION FOR ALLEVIATING DRY MOUTH SYMPTOMS AND FOR TREATING MOUTH ULCERS - The invention concerns a topical oral composition comprising taurine, propanediol and xylitol and its use for alleviating or eliminating symptoms of dry mouth and/or preventing or treating mouth ulcers. | 2015-11-12 |
20150320702 | COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISEASES OR INJURY - Provided are compounds for the treatment of neurological diseases or injuries, including neurodegenerative diseases, stroke, trauma, epilepsy, acute and chronic kidney injuries, diabetes mellitus, and/or seizures. In some embodiments, derivatives of vitamin K are provided. | 2015-11-12 |
20150320703 | COMBINATION OF (3S,3S') 4,4'-DISULFANEDIYLBIS(3-AMINOBUTANE 1-SULFONIC ACID) AND A SECOND ANTIHYPERTENSIVE AGENT - The present invention relates to a pharmaceutical composition comprising, in at least one pharmaceutically acceptable support or vehicle, a combination of (3S,3S′)4,4′-disulfanediylbis(3-aminobutane 1-sulfonic acid) or a pharmaceutically acceptable salt or solvate thereof and a second active ingredient selected from the group consisting of angiotensin I converting enzyme inhibitors and angiotensin II receptor type I antagonists. Said composition is particularly useful for the treatment of hypertension and related diseases and conditions. | 2015-11-12 |
20150320704 | COMPOSITIONS AND METHODS FOR TREATMENT OF HAIR LOSS - Potassium ion channel opening agents, other than ATP-sensitive potassium channel opening agents, have the ability to stimulate hair growth when topically applied to the scalp. | 2015-11-12 |
20150320705 | METHOD OF INHIBITING OR TREATING AMYOTROPHIC LATERAL SCLEROSIS WITH PHENOXYALKYLCARBOXYLIC ACIDS - A compound of Formula (I), or a metabolite thereof, or an ester of the compound of Formula (I) or the metabolite thereof, or a pharmaceutically acceptable salt of each thereof | 2015-11-12 |
20150320706 | FORMULATIONS AND METHODS OF TREATING ALZHEIMER'S DISEASE AND OTHER PROTEINOPATHIES BY COMBINATION THERAPY - Administration of a 1-phenylalkanecarboxylic acid before, after, or a concurrently with a therapeutically effective amount of one or more of the following: (1) β-amyloid peptides level reducers, (2) pathogenic level tau reducers, (3) microtubule stabilizers, (4) agents capable or removing atherosclerotic plaques, (5) agents that lower circulating levels of β-amyloid and tau, (6) modulators of autophagy, (7) neurotransmitter levels regulators, (8) GABA(A) α5 Receptor Antagonists, and (9) additional agents that help maintain and/or restore cognitive function and functional deficits of AD, and/or slow down decline in cognitive functions and functional deficits in AD, is useful for prevention or therapeutical treatment of proteinopathies and/or neurodegenerative diseases. | 2015-11-12 |
20150320707 | TREATMENT OF PAIN WITH TOPICAL DICLOFENAC - The field involves compositions useful for pain relief, including diclofenac solution and gel formulations, in particular methods of use thereof, articles of manufacture and kits that provide novel preclinical, clinical and other information to users. | 2015-11-12 |
20150320708 | TREATMENT OF PAIN WITH TOPICAL DICLOFENAC - The field involves compositions useful for pain relief, including diclofenac solution and gel formulations, in particular methods of use thereof, articles of manufacture and kits that provide novel preclinical, clinical and other information to users. | 2015-11-12 |
20150320709 | METHODS AND COMPOSITIONS FOR FACILITATING WEIGHT LOSS BY ADMINISTRATION OF THYROID HORMONES - The present invention provides methods and compositions for facilitating weight loss in subjects who are undergoing a weight loss regimen by administration of thyroid hormones, for example, T | 2015-11-12 |
20150320710 | ARGININE-CONTAINING TOPICAL COMPOSITION - A composition for topical application to a mucosal body site contains a combination of L-arginine, niacin, and a cooling compound. In one embodiment the composition contains from about 2% to about 7% by weight of a nitric oxide releasing substance selected from the group consisting of L-arginine, L-arginine salts and L-arginine derivatives. The composition also contains from about 0.05% to about 0.5% by weight niacin, and from about 0.1% to about 1% by weight of at least one compound capable of providing a sensation of cooling to the body site of application. | 2015-11-12 |
20150320711 | Capsules Containing High Doses of Levodopa for Pulmonary Use - The present invention provides a capsule containing an inhalable powder composition wherein the composition comprises about 75% by weight or more levodopa, dipalmitoylphosphatidylcholine (DPPC) and a salt characterized by a working density of less than about 100 g/L. The invention further provides a capsule containing an inhalable powder composition wherein the composition comprises about 75% by weight or more levodopa, dipalmitoylphosphatidylcholine (DPPC) and a salt characterized by a working density of less than about 100 g/L wherein the capsule material comprises hydroxypropylmethylcellulose (HPMC) and titanium dioxide. | 2015-11-12 |
20150320712 | Nutritional Composition for Gastrostomy-Tube Patients - A nutritional composition for gastrostomy-tube patients who are at an increased development risk of aspiration pneumonia and require careful risk management, which can be more safely consumed by gastrostomy-tube patients while suppressing the development of aspiration pneumonia, is administered to those patients who require risk management for aspiration pneumonia, and contains a protein source, a carbohydrate source, and a lipid source, the protein source including only amino acids. | 2015-11-12 |
20150320713 | RAPID-ACTING, BLOOD-ARGININE-LEVEL-INCREASABLE ORAL PREPARATION COMPRISING CITRULLINE AND ARGININE - The invention provides a rapid-acting, blood NO | 2015-11-12 |
20150320714 | POWDEROUS FORMULATION - The present invention relates to a powderous formulation comprising powder particles. These powder particles do comprise polyunsaturated oils, especially polyunsaturated fatty acids, and the powder do have at the same time an excellent sensory profile, a fine particle structure and a high oil loading. | 2015-11-12 |
20150320715 | DPA-ENRICHED COMPOSITIONS OF OMEGA-3 POLYUNSATURATED FATTY ACIDS IN FREE ACID FORM - DPA-enriched pharmaceutical compositions of polyunsaturated fatty acids in free acid form, therapeutic methods for their use, and processes for refining the compositions from fish oil are presented. | 2015-11-12 |